| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $282.9M | -3.8% |
| Cost of Revenue | $69.0M | +3.5% |
| Gross Profit | $213.9M | -5.9% |
| R&D Expense | $123.3M | +22.1% |
| SG&A Expense | $192.9M | +7.6% |
| Operating Income | -$82.3M | -150.4% |
| Interest Expense | $13.7M | +2.6% |
| Pre-tax Income | -$98.4M | -99.8% |
| Income Tax | $766K |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $119.5M | +18.7% |
| Accounts Receivable | $36.1M | +7.9% |
| Inventory | $37.8M | +64.4% |
| Current Assets | $443.9M | -8.7% |
| Total Assets | $1.00B | -4.5% |
| Current Liabilities | $72.4M | +14.2% |
| Total Liabilities | $472.4M | +2.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.1M | -233.9% |
| Capital Expenditures | $30.3M | -36.7% |
| Investing Cash Flow | $44.8M | +176.9% |
| Financing Cash Flow | $6.3M | -84.1% |
| Free Cash Flow | -$63.3M | -174.5% |
| +135.0% |
| Net Income | -$99.2M | -100.0% |
| EPS (Basic) | -$2.09 | -95.3% |
| EPS (Diluted) | -$2.09 | -95.3% |
| Stockholders' Equity |
| $530.0M |
| -9.7% |